Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Rxi Pharmaceuticals Corp (NASDAQ:RXII)

0.6242
Delayed Data
As of Jun 23
 -0.0108 / -1.70%
Today’s Change
0.51
Today|||52-Week Range
3.27
-12.66%
Year-to-Date
No recent news for Rxi Pharmaceuticals Corp.

Today’s Trading

Previous close0.64
Today’s open0.65
Day’s range0.60 - 0.65
Volume139,218
Average volume (3 months)721,062
Market cap$13.8M
Dividend yield--
Data as of 3:59pm ET, 06/23/2017

Growth & Valuation

Earnings growth (last year)+21.90%
Earnings growth (this year)+44.46%
Earnings growth (next 5 years)--
Revenue growth (last year)-44.12%
P/E ratioNM
Price/Sales253.76
Price/Book1.11

Competitors

 Today’s
change
Today’s
% change
GENEGenetic Technologies...-0.01-0.82%
CBMXCombiMatrix Corp-0.05-0.98%
VTGNVistaGen Therapeutic...-0.03-1.67%
XTNTXtant Medical Holdin...+0.06+9.16%
Data as of 3:59pm ET, 06/23/2017

Financials

Next reporting dateAugust 17, 2017
EPS forecast (this quarter)-$0.20
Annual revenue (last year)$19.0K
Annual profit (last year)-$9.0M
Net profit margin-47,336.84%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, CFO &
Director
Geert Cauwenbergh
Vice President-
Research
Karen Bulock
Corporate headquarters
Marlborough, Massachusetts

Forecasts